NewsAlways Pure Organics Makes £3m Continental Swoop For Leading...

Always Pure Organics Makes £3m Continental Swoop For Leading B2C Hemp And CBD Player

-

FAST-GROWING UK cannabis wholesaler Always Pure Organics has acquired two Belgian companies – Distribution Legal Hemp and NexGen – for £3m. 

Manchester-based APO says the ‘post-Brexit acquisition’ will strengthen its presence in its key European market – where 80% of its clients are based – and boost its presence in the fast-growing CBD flower market.

Joeri Perneel, CEO of Distribution Legal Hemp (DLH) and NexGen, will start in a newly-created role as APO’s Chief Commercial Officer, with a focus on the companies’ activities in the Benelux and French markets. 

The deal has been funded out of APO’s balance sheet with its Scottish Co-Founder and CEO Gavin Ogilvie taking the helm at the enlarged company.

CBD Flower Market To Grow

Mr Ogilvie said: “As part of our ambitious global expansion plans, DLH gives us a brilliant complementary business. 

“Belgium is the first nation in Europe to legalise the use of CBD flower through their existing tobacco substitutes legislation, so by buying DLH we have instantly secured 75% of Belgium’s CBD flower market. 

“It’s likely that France will also seek to regulate the CBD flower through the same legal mechanism before long, and APO will therefore be in a strong strategic position to take full advantage of this new market when it opens.”

DLH’s CEO, Joeri Perneel, said: “Both companies have known each other and worked together for more than  two years. 

Rapidly-Growing Businesses

“The deal is on all levels complementary. DLH/NexGen is the market leader in Belgium within the segment of tobacco substitute and is a pioneer in the segment of wellness. We are only at the beginning of the journey and I’m happy to work with APO to build this new group into a world-class player.”

Over the past two years, both companies have grown rapidly. APO has increased staff from six to 62 and, in the past year, revenues have grown 215% with a 2021 forecast of £12.6m. Similarly DLH grew 170% in the past year. 

APO – a top three wholesale and white label market leader in the UK, Japan, and Europe – says the purchase gives its access to a much-needed distribution hub and a foothold in the fast-growing European CBD retail sector.

DLH has a number of successful B2C wellness retail brands – Pure CBD, Pet CBD and market leading tobacco substitute brands Sensy and Jane’s Garden – with direct access to multiple major retail chains selling tobacco substitute and wellness products across Europe. 

Main Image: L-R; Joeri Perneel and Gavin Ogilvie



Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

European Cannabis Market Leader Bloomwell Group Secures $10m Investment

The Bloomwell Group has successfully closed a seed funding round of over $10 million dollars—the highest publicly known seed investment...

German Hemp Farm Numbers Up 900% In Seven Years – As industry Calls For Post-Election Reform

THE number of German farms growing industrial hemp has hit 863 – the highest figure since the federal republic...

US Company Set To Launch UK Medical Cannabis Study In Partnership With Manchester University

A GROUND-BREAKING human pilot study centred on the University of Manchester could provide answers to using cannabis as a...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...

You might also likeRELATED
Recommended to you